Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07510048 · ClinicalTrials.gov registry record · Phase 2
Combatting HIV Or Other STIs Early (CHOOSE)
A Phase 2 study, sponsored by Westat.
- Not yet
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT07510048 is a Phase 2 study that has not yet begun recruiting, run by Westat. The registered enrollment target is 200 participants.
The verdict
NCT07510048, a Phase 2 study, has not yet begun recruiting, sponsored by Westat.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The overarching goal of this project is to optimize the PrEP Choice integrated mHealth package and assess the efficacy and cost of PrEP Choice on PrEP initiation and adherence among young people. It is hypothesized that PrEP Choice will improve HIV PrEP uptake and adherence among young people and will be cost-effective to deliver to young people in the United States (U.S.). This study will also assess the uptake, adherence, and acceptability of DoxyPEP among young people.
Interventions
- OTHER Standard of care and PrEP Choice at Enrollment
- OTHER Standard of care followed by PrEP Choice at Month 9
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-04 |
| Est. Completion | 2029-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07510048
The ClinicalTrials.gov registry entry for NCT07510048 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Westat, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care and PrEP Choice at Enrollment is the first listed.
NCT07510048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07510048 about?
NCT07510048 is a clinical study titled "Combatting HIV Or Other STIs Early (CHOOSE)". The overarching goal of this project is to optimize the PrEP Choice integrated mHealth package and assess the efficacy and cost of PrEP Choice on PrEP initiation and adherence among young people. It is hypothesized that PrEP Choice will improve HIV PrEP uptake and adherence among young people and wi...
What is the current status of trial NCT07510048?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2026-04. Estimated completion is 2029-09.
What interventions are being tested in trial NCT07510048?
The interventions under investigation include: Standard of care and PrEP Choice at Enrollment (OTHER), Standard of care followed by PrEP Choice at Month 9 (OTHER).
Who is sponsoring clinical trial NCT07510048?
This trial is sponsored by Westat, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.